• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Essity

256.80 SEK

+1.10 %

1,848 following

ESSITY B

NASDAQ Stockholm

Personal Goods

Consumer Goods & Services

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+1.10 %
+5.51 %
-3.78 %
-3.17 %
-1.34 %
-6.92 %
-12.35 %
-11.17 %
+3.34 %

Essity operates in the hygiene and health industry and focuses on the development, manufacturing and distribution of products within personal care, incontinence and medical care. The company's products are aimed at private individuals and healthcare institutions. The operations are global with a main presence in Europe, North America and Asia. Essity was founded in 2017 and is headquartered in Stockholm, Sweden.

Read more
Market cap
175.12B SEK
Turnover
229.14M SEK
Revenue
-
EBIT %
-
P/E
18.88
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Webcasts
Press releases
ShowingAll content types

Forum discussions
Let’s continue the almost dead discussion about a quality company. Essity has continued its steady progress. The dividend is growing again and the balance sheet keeps improving. The company is starting to have the strength to either buy back more of its own shares or embark on complementar...
2/14/2025, 12:25 PM
by WidemoatInvesting
8
Essity has very high-quality businesses. The company went public at a valuation that was a bit too high, but the valuation has now settled at reasonable levels. If growth continues, the company’s value should catch up at some point. I would consider it a company with a similar growth...
2/21/2024, 10:51 AM
by WidemoatInvesting
6
Much has happened since the last post. Over the past three years, Essity has diversified by making numerous acquisitions: 2021 -Full acquisition of ABIGO Medical and Asaleo Care (previously partial ownership). -Ownership stake in Productos Familia S.A. was increased to 95.8%. -Acquired...
2/21/2024, 9:16 AM
by Raha-aasi
6
Essity will have a couple of rough quartals ahead of them. That is given, due to lockdowns and costs concerns driven by mass price increases. But that said, Essity is doing everything right, and if I want to be in this space I prefer Essity over KMB, which is heavily in debt (as ...
4/27/2021, 2:20 PM
by 916
4
Essity is by its nature a ‘boring’ company. But for me its one of the best quality companies in the Nordics (I am a value, long-term investor.) If you have a long-term time horizon and have the patience to wait owning this share it will eventually prove to be successful. The short...
2/4/2021, 1:40 PM
by 916
4
Let’s bring this thread back up due to the Q3 results. https://masdpstatic.azureedge.net/essity/7039f0d1-f52a-44f4-9327-1a7bb3cbea56/Presentation-Interim-Report-Q3-2020.pdf https://masdpstatic.azureedge.net/essity/cb2c23c0-7d0c-4895-b92e-36c07b38d904/Essity_report_eng.pdf Revenue...
10/23/2020, 8:24 AM
by kettunen
3
At least aging population, longer life expectancy, growth in world population and income(Essity is present on emerging markets) as well as increased awareness of the importance of hygiene(emerging markets). How well these trends will translate to revenue growth for Essity is of course...
1/23/2020, 10:42 AM
by purple
2
Read more on our forum
Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
16/7
2026

Interim report Q2'26

22/10
2026

Interim report Q3'26

21/1
2027

Annual report '26

Press release6/3/2026, 6:00 AM

Essity utnämnt till Supplier Engagement Leader av CDP för sjunde året i rad

Essity
Press release6/3/2026, 6:00 AM

Essity recognized on CDP Supplier Engagement A List for seventh consecutive year

Essity
Regulatory press release6/1/2026, 6:44 AM

Återköp av aktier av serie B i Essity under vecka 22, 2026

Essity

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release6/1/2026, 6:44 AM

Buyback of Class B shares in Essity during week 22, 2026

Essity
Regulatory press release5/25/2026, 7:45 AM

Återköp av aktier av serie B i Essity under vecka 21, 2026

Essity
Regulatory press release5/25/2026, 7:45 AM

Buyback of Class B shares in Essity during week 21, 2026

Essity
Regulatory press release5/18/2026, 8:06 AM

Buyback of Class B shares in Essity during week 20, 2026

Essity
Regulatory press release5/18/2026, 8:06 AM

Återköp av aktier av serie B i Essity under vecka 20, 2026

Essity
Regulatory press release5/7/2026, 5:00 AM

Today Essity hosts its Capital Markets Day - Accelerating progress by sharpening focus and execution

Essity
Regulatory press release5/7/2026, 5:00 AM

Idag håller Essity kapitalmarknadsdag - Accelerating progress by sharpening focus and execution

Essity
Regulatory press release5/6/2026, 5:25 PM

Essity inleder en strategisk översyn av affärsområdet Consumer Tissue

Essity
Regulatory press release5/6/2026, 5:25 PM

Essity initiates strategic review of the Consumer Tissue business area

Essity
Regulatory press release4/30/2026, 6:00 AM

Changes in number of shares and votes in Essity

Essity
Regulatory press release4/30/2026, 6:00 AM

Förändring av antal aktier och röster i Essity

Essity
Press release4/28/2026, 6:00 AM

Agenda for Essity's Capital Markets Day Accelerating progress by sharpening focus and execution

Essity
Press release4/28/2026, 6:00 AM

Agenda för Essitys kapitalmarknadsdag Accelerating progress by sharpening focus and execution

Essity
Regulatory press release4/23/2026, 5:00 AM

Essity: Delårsrapport Kvartal 1 2026

Essity
Regulatory press release4/23/2026, 5:00 AM

Essity: Interim Report Quarter 1, 2026

Essity
Regulatory press release4/22/2026, 3:35 PM

Essity decides on new share buyback program of SEK 3bn

Essity
Regulatory press release4/22/2026, 3:35 PM

Essity beslutar om nytt aktieåterköpsprogram om 3 miljarder SEK

Essity